Compounds > hexamethylene bisacetamide

hexamethylene bisacetamide and vorinostat

hexamethylene bisacetamide has been researched along with vorinostat in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breslow, R; Emiliani, S; Marks, PA; Richon, VM; Rifkind, RA; Verdin, E; Webb, Y1
McFarlane, M; Preston, CM1
Arcangeli, A; Carlà, M; Guidelli, R; Herrero, R; Moncelli, MR; Olivotto, M1
Anderson, J; Archin, NM; Bosque, A; Chan, J; Famiglietti, M; Greene, WC; Kashuba, A; Lewin, SR; Margolis, DM; Mau, M; Planelles, V; Ruelas, D; Saleh, S; Shirakawa, K; Siliciano, RF; Singhania, A; Soto, PC; Spina, CA; Terry, VH; Verdin, E; Woelk, C; Wooden, S; Xing, S1
Cheng, WJ; Churchill, MJ; Ellett, AM; Gorry, PR; Gray, LR; Jacobson, JC; Lewin, SR; Lu, HK; Moso, MA; On, H; Papaioannou, C; Purcell, DF; Raison, JA; Roberts, E; Wesselingh, SL1

Other Studies

5 other study(ies) available for hexamethylene bisacetamide and vorinostat

ArticleYear
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.
    Proceedings of the National Academy of Sciences of the United States of America, 1998, Mar-17, Volume: 95, Issue:6

    Topics: Acetamides; Animals; Carcinoma; Cell Differentiation; Cell Line, Transformed; Cell Transformation, Neoplastic; Cinnamates; Drug Resistance; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Leukemia, Erythroblastic, Acute; Malonates; Mice; Urinary Bladder Neoplasms; Vorinostat

1998
Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16.
    Virology, 1998, Sep-30, Volume: 249, Issue:2

    Topics: Acetamides; Animals; Cell Differentiation; DNA Damage; Genes, Immediate-Early; Genes, Viral; Genetic Complementation Test; Herpes Simplex Virus Protein Vmw65; Herpesvirus 1, Human; Hydroxamic Acids; Mice; Mutation; Niacinamide; Promoter Regions, Genetic; Tumor Cells, Cultured; Virus Replication; Vorinostat

1998
Hybrid polar compounds produce a positive shift in the surface dipole potential of self-assembled phospholipid monolayers.
    Biochimica et biophysica acta, 2000, Jun-01, Volume: 1466, Issue:1-2

    Topics: Absorption; Acetamides; Antineoplastic Agents; Hydroxamic Acids; Malonates; Mercury; Molecular Structure; Phosphatidylcholines; Phosphatidylserines; Phospholipids; Vorinostat

2000
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.
    PLoS pathogens, 2013, Volume: 9, Issue:12

    Topics: Acetamides; Adult; CD4-Positive T-Lymphocytes; Cells, Cultured; HEK293 Cells; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Hydroxamic Acids; Interleukin-7; Jurkat Cells; Models, Biological; Virus Activation; Virus Latency; Vorinostat

2013
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
    Journal of neurovirology, 2016, Volume: 22, Issue:4

    Topics: Acetamides; Astrocytes; Azepines; Cell Line; Cell Survival; Depsipeptides; Disulfiram; Fetus; Histone Deacetylase Inhibitors; HIV-1; Humans; Hydroxamic Acids; Indoles; Macrophages; Neurons; Panobinostat; Piperazines; Primary Cell Culture; Transcription, Genetic; Triazoles; Virus Activation; Virus Latency; Virus Replication; Vorinostat

2016